XTL Biopharmaceuticals Ltd.

XTL Biopharmaceuticals Ltd. financial statements

XTL Biopharmaceuticals Ltd.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2024

RevenueUSD 451K20-F
Net income−USD 1.03M20-F
Cash and equivalentsUSD 371K20-F
Total debtUSD 138K20-F

XTL Biopharmaceuticals Ltd. financials on 6ix · XTL Biopharmaceuticals Ltd. on 6ix